351
Bibliography
Abelson, R. & Singer, N. 2011. Pharmacists fight the rise of mail order. New York Times, 3 March. Available: http://www.nytimes.com/2011/03/04/business/04drug.html?_r=0. Date of access: 10 April 2011
Academy of Managed Care Pharmacy. 2008. Drug utilization review. Available:
http://www.amcp.org/workarea/downloadasset.aspx?id=9296. Date of access: 4 June 2012. Adler, C.H., Heintz, J.G., Joyce, J.N., Beach, T. & Caviness, J.N. 2002. Motor impairment in normal ageing, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donors. Parkinsonian and
related disorders, 9:103-10.
Agency for Healthcare Research and Quality. 2007. Medical expenditure panel survey component data: Prescription medicines – mean and median expenses per person with expense and Distribution of expenses by source of payment. Available:
www.meps.ahrg.gov/mepsweb. Date of access: 14 April 2009.
Aitken, M., Berndt, E.R.& Cutler, D.M. 2009. Prescription drug spending trends in the United States: Looking beyond the turning point. Health affairs, 28(1): 151-60.
Aldous C., Rheeder P. & Esterhuizen, T. 2013. Writing your first clinical research protocol. Juta and Company: Claremont.
American Heritage® Medical Dictionary. 2007. Chronic. Available: http://medical-dictionary.thefreedictionary.com/chronic. Date of access: 10 March 2010.
American Thyroid Association. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Available: http://www.guideline.gov/content.aspx?id=36633. Date of access: 1 September 2013.
ANC. 2009. National health insurance: a revolution in health care. ANC Today, 9(3). Available: http://www.anc.org.za/ancdocs/anctoday/2009/at03.htm. Date of access: 4 July 2012.
Anderson, G. & Markovich, P. 2010. Multinational comparisons of health systems data, 2008. The Commonwealth Fund. Available:
http://www.commonwealthfund.org/Publications/Chartbooks/2010/Apr/Multinational-Comparisonsof-Health-Systems-Data-2008.aspx. Date of access: 16 September 2012.
352
Andersson, K., Bergström, G., Petzold, M.G. & Carlsten, A.2007. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Health policy, 81(2-3):376-84.
Andrade, S.E., Kahler, K.H. & Frech, F. 2006. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and drug safety, 15(8): 565-77.
Angalakuditi, M. & Gomes, J. 2011. Retrospective drug utilization review: Impact of pharmacist interventions on physician prescribing. ClinicoEconomics and outcomes research, 3:105-8. Angelberger, S., Vogelsang, H., Novacek, G., Mieshler, W., Dejaco, C., Gangl, A. & Reinisch, W. 2009. Public awareness of Crohn’s disease and ulcerative colitis: a national survey. Journal
of Crohn's and Colitis, 3:157-61.
Anell, A. & Willis, M. 2000. International comparison of health care systems. Bulletin of the
World Health Organization, 78(6):770-8.
Arnold, R.G. & Balu, S. 2010. Retrospective database analysis. (In Arnold R.J. ed.
Pharmacoeconomics: from theory to practice. 1st ed. Boca Raton, FL: Taylor & Francis Group, CRC Press, p. 59–82).
ASHP. 1993. ASHP statement on pharmaceutical care. American journal of hospital pharmacy, 50:1720–3.
Åstrand, B., Montelius, E., Petersson, G. & Ekedahl, A. 2009. Assessment of ePrescription quality: An observational study at three mail-order pharmacies. BMC medical informatics and
decision making, 9(8):1-8.
Australian Institute of Health and Welfare. 2000. Australia’s Health 2000.The seventh biennial health report of the Australian Institute of Health and Welfare.
https://www.aihw.gov.au/publication-detail/?id=6442467153. Date of access: 12 May 2010. Babar, Z.U., Grover, P., Stewart, J., Hogg, M., Short, L., Seo, H.G. & Rew, A. 2011. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
Research in social and administrative pharmacy, 7(3):294-305.
Badjatya, J.K. 2013. Generic drugs market: Brand versus generic. Journal of drug delivery &
353
Baker, P.A. 2010. From apartheid to neoliberalism: Health equity in post-apartheid South Africa. International journal of health services, 40(1):79–95.
Ball, S. 2005. Diabetes Insipidus. Medicine, 33(11):18-9.
Beardsall, K. & Ogilvy-Stuart, A.L. 2004. Congenital hypothyroidism. Current pediatrics, 14:422-9.
Berg, S. 2006. Negotiating “asthma control”: This buzzword is the new focus of asthma care. Available:
http://www.researchgate.net/publication/257489992_Negotiating_asthma_control__This_buzzw ord_is_the_new_focus_of_asthma_care. Date of access: 23 May 2010.
Berger, M.L., Mamdani, M., Atkins, D. & Johnson, M.L. 2009. Good research practices for comparative effectiveness research: Defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources. Value in health, 12(8):1044-1051.
Berry, L.L. & Mirabito, A.M. 2010. Innovative health care delivery. Business horizons, 53(1):157-169.
Bester, M. & Badenhorst, E. 2009. Medicines review 2008. Mediscor PBM. Bester, M. & Badenhorst, E. 2010. Medicines review 2009. Mediscor PBM. Bester, M. & Badenhorst, E. 2011. Medicines review 2010. Mediscor PBM.
Bester, M. 2013. Private sector chronic medication [personal interview]. 22 April. Centurion. Bester, M., Brews, M. & Hammann, E. 2005. Medicines review. Mediscor PBM.
Bevan, J.L. 2006. Diabetes Mellitus: a review of select ADA standards for 2006. The journal for
nurse practitioners, 2(10):674-9.
BHF. 2008. Prescribed minimum benefits. Available: http://www.bhfglobal.com/prescribed-minimum-benefits. Date of access: 15 September 2013.
Bhorat, H. & Van der Westhuizen, C. 2008. Economic growth, poverty and inequality in South Africa: The first decade of democracy. DPRU. www.commerce.uct.ac.za/.../Carlene1995_ 2005%20growth%20&_poverty_28march_updated.pdf. Date of access: 7 February 2011. Bihl, G.R. 2002. Highlights from nephrology 2002 - South African renal society congress.
Medscape transplantation, 3(2). Available: http://www.medscape.com/viewarticle/442367_3.
354
Birn, A.E. & Nixon, S. 2010. Canada’s health care system: a relevant approach for South Africa? South African medical journal, 100:516-20.
Björkman, I., Bernsten, C.B. & Sanner, M. 2008. Care ideologies reflected in four conceptions of pharmaceutical care. Research in social and administrative pharmacy, 4:332-42.
Bongani, M.M., Flisher, A.J., Umesh G.L., Sitas, F., Tollman, S.M. & Bradshaw, D. 2009. The burden of non-communicable diseases in South Africa. The lancet, 374:934-47.
Boudík, F., Reissigová, J., Hrach, J., Tomecková, M., Bultas, J., Anger, Z., Aschermann, M. & Zvárová , J. 2006. Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis, 184:86-93.
Boyton, R.J. 2008. Bronchiectasis. Medicine, 36(6): 315-20.
Bradshaw, D., Schneider, M., Joubert,J., Groenewald, P., Lewin, S., Steyn, K., Vost, T., Laubscher, R., Nannan, N., Noijilana, B. & Pieterse, D. 2007. A comparative risk assessment for South Africa on 2000: Towards promoting health and preventing disease. South African
medical journal, 97(7):637-41.
Brunton, L.L.,Lazo, S. & Parker,K.L. eds. 2006. Goodman & Gilman's The Pharmacological
Basis of Therapeutics, 11th Edition. United States of America: The McGraw-Hill Companies,
Inc.
Burger, J.R. 2012. A drug utilisation review of the concept of metabolic syndrome using a South African medicines claims database. Available: http://dspace.nwu.ac.za/handle/10394/8072. Date of access: 19 August 2013.
Bush, J., Langley, C.A. & Wilson, K.A. 2009.The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Research in social and administrative pharmacy, 5:305–18.
Business Dictionary. 2011. Definition: Age. Available: http://www.businessdictionary.com/ definition/chronological-age.html#ixzz2fc8UAnEN. Date of access: 2 October 2011.
Business Dictionary. 2013. Chi-Square C2-Test. Available: http://www.businessdictionary.com/ definition/chi-square-c2-test.html. Date of access: 3 September 2013.
Busse, W.W. 2011. Asthma diagnosis and treatment: Filling in the information Gaps. Journal of
355
Cameron, A., Ewen, M., Rossdegnan, D., Bal,l D. & Laing, R. 2009. Medicine prices, availability, and affordability in 36 developing and middle- income countries: a secondary analysis. The
lancet, 373(9659): 240–49.
Cameron, A.,Roubos,I., Ewen,M., Mantel-Teeuwisse, A.K., Leufkens , H.G.G. & Laing, R.O. 2011. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bulletin of the World Health Organization, 89:412-21.
Cancer Research UK. 2012. Cancer statistics. Available:
http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/age/. Date of access: 10 December 2012.
Carney, R.M. & Freedland, K.E. 2003. Depression, mortality and medical morbidity in patients with coronary heart disease. Biological psychiatry, 54:241-7.
Cazzola, M., Donner, C.F. & Hanania, N.A. 2007.One hundred years of chronic obstructive pulmonary disease (COPD). Respiratory medicine, 101(6):1049-1065.
Centers for Disease Control and Prevention. 2006. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation. MMWR, 55(40):1089–1092. Available:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5540a2.htm. Date of access: 8 June 2011. Centers for Disease Control and Prevention. 2011. Epilepsy – facts and statistics. Available: http://www.cdc.gov/Epilepsy/. Date of access: 5 October 2011.
Centers for Disease Control and Prevention. 2013. Surveillance case definition. Available: http://www.cdc.gov/hiv/statistics/recommendations/terms.html. Date of access: 28 September 2013.
Chakera, A.J. 2010. Addison disease in adults: Diagnosis and management. The American
journal of medicine. 123(5):409-13.
Chanez, P., Wenze, S.E.,l, Anderson, G.P., J.M., Anto, Bel, E.H.,MD, Boulet, L., Brightling, C.E., Busse, W.W.,Castro, M.,Dahlen, B., Dahlen, S.E., Fabbri, L.M., Holgate,S.T.,Humbert, M., Gaga, M., Joos, G.F.,Levy,B.. Rabe, K.F., Sterk, P.J., Wilson, S.J. & Vachier, I. 2007. Severe asthma in adults: What are the important questions? Journal of allergy and clinical immunology, 119:1337-48.
Chang, H., Chang, W., Das, S. & Li, S. 2004. Health care regulation and the operating efficiency of hospitals: Evidence from Taiwan. Journal of accounting and public policy, 23(1):483-510.
356
Chen, P. & Cheng, S. 2008. Depression in Parkinson disease: Current understanding and treatment. International journal of gerontology, 2(4):172-82.
Chen, L.M., Jha, A.K. & Guterman, S. 2010. The hospital cost of care, quality of care, and readmission rates: Penny-wise and pound-foolish? Archives of Internal Medicine, 170(4):340-6. Childs, B. 2009. The private hospital review: Quantifying the potential capacity in the private hospital sector to absorb an influx of newly covered patients. Available:
http://www.mediclinic.co.za/about/ Documents/Private_Hospital_Review_2009_FINAL1.pdf. Date of access: 12 June 2012.
Chockalingam, A., Campbell, N.R. & Fodo, J.G. 2006. Worldwide epidemic of hypertension.
Canadian journal of cardiology, 22(7):553-55.
Chong, C.P., March, G., Clark, A., Gilbert, A., Hassalic, M.A. & Baharia, M.B. 2011. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health policy, 99:139-148.
Choudhry,N.K. & Shrank, W.H. 2010. Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance. The New England journal of medicine, 363(20):1885-7.
Chua, G.N., Hassali, M.A., Shafie, A.A. & Awaisu, A. 2010. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health policy, 95(2-3):229-35.
Clark, B.E., Siracuse, M.V. & Garis, R.I. 2009. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans. Research in social and
administrative pharmacy, (5)2:133-42.
Cleland, J.G.F., Khand, A. & Clark, A. 2001. The heart failure epidemic: exactly how big is it?
European Heart Journal, 22(8): 623–6.
CMS. 2009a. Prescribed minimum benefits. 10 things no one tells you about PMBs. Available: http://www.medicalschemes.com/publications/publications.aspx?catid=16. Date of access: 18 November 2009.
CMS. 2009b. Unlock your chronic benefits. Available:
http://www.medicalschemes.com/publications/ZipPublications/CMScript/CMScript%20Jan%200 9%20-%20unlock%20your%20chronic%20benefits.pdf. Date of access: 9 July 2009.
357 CMS.2009c. Designated service providers. Available:
http://www.medicalschemes.com/medical_schemes_pmb/designated_service_providers.htm. Date of access: 4 April 2010.
CMS. 2010a. Council for medical schemes annual report 2009-2010. Available: www.medicalschemes.com. Date of access: 10 October 2010.
CMS. 2010b. Relationships in the industry: what beneficiaries should know. CMS News, 15 Aug. Available: http://www.medicalschemes.com/publications/ZipPublications/CMS%20News/ CMSNews3Of2009_2010_20100419.pdf. Date of access: 18 January 2011.
CMS. 2011. Annual report 2010-2011. Available:
http://www.medicalschemes.com/Publications.aspx .Date of access: 24 Sep. 2011. Cohen, J. 1988. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates.
Commonwealth Fund. 2010. International Profiles of Health Care Systems. Australia, Canada, Denmark, England, France, Germany, Italy, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States. Available:
http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2010/Jun/1417_ Squires_Intl_Profiles_622.pdf. Date of access: 12 August 2012.
Coovadia, H., Jewkes, R., Barron, P., Sanders, D. & McIntyre, D. 2009. The health and health system of South Africa: Historical roots of current public health challenges. Lancet, 374:817-34. Cox, E. & Mager, D. 2008. Is compliance really better in home delivery: Evidence across three chronic therapy classes. Available: http://www.express-scripts.com/research/studies/. Date of access: 19 May 2009.
Cramer, J.A., Roy, A., Burrell, A., Fairchild, C.J., Fuldeore, M.J., Ollendorf, D.A. & Wong,P.K. 2008. Medication compliance and persistence: Terminology and definitions. Value health 11(1):44-7.
Datta, B.N., Cole, D.S & Shortland, G.J. 2011. Hyperlipidaemia. Paediatrics and child health, 21(2):94-8.
Daughenbaugh, L. 2007. Cardiomyopathy. Journal for nurse practitioners, 3(4):248-58. Decollogny, A., Eggli, Y., Halfon, P. & Lufkin, T.M. 2011. Determinants of generic drug substitution in Switzerland. BMC health services research ,11(17):1-12.
358
Deloittes. 2010. Insights to the high-level financial contribution of the pharmaceutical Industry in South Africa. Available: http://www.imsa.org.za/files/Library/
IMSA%20Position%20Statements%20and%20Issues(1)/010410_PTG%20Deloitte%20Report% 20Final%20v7%20(changes)%20(1).pdf. Date of access: 15 March 2011.
Department of Health. 2003. Opening address to the consultative forum on risk equalisation. Midrand.
Department of Health. 2006a. A national human resources plan for health to provide skilled resources for healthcare adequate to take care of all South Africans. Pretoria.
Department of Health. 2006b. Determination of maximum increase in the single exit price of medicines and scheduled substances up until 1 July 2007. Government Gazette, 29443:R1213, 1 December.
Department of Health. 2008a. Determination of maximum increase in the single exit price of medicines and scheduled substances for 2008. Government Gazette, 30901:513, 27 March. Department of Health. 2008b. Determination of maximum increase in the single exit price of medicines and scheduled substances up until 1 July 2009. Government Gazette, 31735:R1391, 27 December.
Department of Health. 2010a. Determination of maximum increase in the single exit price of medicines and scheduled substances for 2010. Government Gazette, 33034:208, 17 March. Department of Health. 2010b. National department of health strategic plan 2010/11-2012/13 Available: http://www.mm3admin.co.za/documents/docmanager/2D5ED792-878C-4371-9575-8281A96BBB26/00023294.pdf. Date of access : 15 October 2011.
Department of Health. 2011a. National health insurance in South Africa. Available: http://us-cdn.creamermedia.co.za/assets/articles/attachments/34471_nhi.pdf. Date of access: 2 May 2012
Department of Health. 2011b. Regulations relating to a transparent pricing system for medicines and scheduled substances: Amendment (single exit price adjustment for the year 2011).
Government Gazette, 33961:R30, 24 January.
Department of Health. 2012. Standard treatment guidelines and essential medicines list for South Africa. Available: http://www.doh.gov.za/docs/guidelines/2013/stdtreatguide.pdf. Date of access: 15 May 2013.
359
Department of Health .2013. The South African Antiretroviral Treatment Guidelines 2013. Available:
http://www.doh.gov.za/docs/policy/2013/ART_Treatment_Guidelines_Final_25March2013.pdf. Date of access: 28 September 2013.
Deroukakis, M. 2007. Mandatory substitution successful. South African pharmaceutical journal, 97(1):63-4.
Detels, R. 2010. Epidemiology: the foundation of public health. Available:
http://www.ph.ucla.edu/epi/faculty/detels/PH150/Detels_Epidemiology.pdf. Date of access: 12 September 2013.
Devine, S., Vlahiotis,A. & Sundar, H. 2010. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. Journal of
medical economics, 13(2): 203-11.
Devore, J. & Peck, R. 2001. Statistics: The exploration and analysis of data, 4th ed., Belmont, CA: Brooks/Cole.
Diamond, B.J., Johnson, S.K., Kaufman, M. & Graves, L. 2008. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Archives of
neuropsychology, 23:189-99.
Diamantopoulos, A. & Schlegelmilch, B.B. 2000. Taking the fear out of data analysis. Cengage Learning: EMEA.
Dictionary Central. 2011. Direct Costs. Available:
http://www.dictionarycentral.com/definition/direct-cost.html. Date of access : 25 March 2012. DiMasi, J.A,,Hansen, R.W. & Grabowski, G.H. 2003. The price of innovation: new estimates of drug development costs. Journal of health economics, 22:151-85.
Dischem. 2011. About us. Available: http://www.dischem.co.za/
content_view.asp?ArticleID=1293&MenuID=25. Date of access: 8 December 2011.
Doane, D.P. & Seward, L.E. 2007. Applied statistics in business and economics. Burr Ridge: Mcgraw-Hill.
Dorland’s Medical Dictionary for Health Consumers. 2007. Frequency. Available: http://medical-dictionary.thefreedictionary.com/FreQuency. Date of access: 9 June 2008.
360
Doucette,W.R., McDonough, R.P., Klepser, D. & McCarthy,R. 2005. Identifying and Resolving Drug-Related Issues in a Community Pharmacy. Clinical Therapeutics, 27 (7):1104-11.
Dougherty, A. 2008. International Health Care System Comparisons. Available:
http://www.itup.org/Reports/Fresh%20Thinking/International%20Table.pdf. Date of access: 29 November 2009.
Duru, O.K., Schmittdiel, J.A., Dyer, W.T., Parker, M.S., Uratsu, C., Chan, J. & Karter, A. 2010. Mail-order pharmacy use and adherence to diabetes-related medications. The American journal
of managed care, 16(1):33-40.
Du Toit, J., Dames, S. & Boshoff, R. 2008. Centralised dispensing: an affordable solution. South
African pharmaceutical journal, 74(10):18-20.
Econex. 2010a. Health Reform Note 1: The role of primary healthcare in health reform. Available: http://www.econex.co.za/images/stories/
ECONEX_Health%20Reform%20Note_1.pdf. Date of access: 3 January 2011.
Econex. 2010b. Health Reform Note 4: Integration of the public and private sectors under a National Health Insurance (NHI) system in SA. Available: http://www.econex.co.za/. Date of access: 24 April 2011.
Edwards, M.H. & Edwards, C.J. Rheumatoid arthritis: changing beyond recognition. Orthopedics
and trauma, 24(6):405-9
Express Scripts. 2010. Plan design review guide. Available:
https://host1.medcohealth.com/art/corporate/pdf/plan_design_review_guide.pdf. Date of access:2 February 2011.
Egede, L.E. & Ellis, C. 2010. Diabetes and depression: global perspectives. Diabetes research
and clinical practice, 87(3):302-12.
Eggli, Y., Halfon, P., Chikhi, M. & Bandi, T. 2006. Ambulatory healthcare information system: a conceptual framework. Health Policy, 78(1):26-38.
Ehrlich, R. & Jithoo, A. 2006. Chronic respiratory diseases. (In Steyn, K., Fourie, J. & Temple, N. eds. Chronic diseases of lifestyle in South Africa since 1995 – 2005. Technical report. Cape Town: South African Medical Research Council. p. 122-41). Available:
361
Eisenberg, J.M. 1989. Clinical economics: a guide to economic analysis of clinical practices.
Journal of the American medical association, 262(20):2879-86.
Elger, C.W. & Schmidt, D. Modern management of epilepsy: A practical approach. Epilepsy &
behavior ,12:501-39.
Encyclo. 2011. Definition of chronological age. Available:
http://www.encyclo.co.uk/define/chronological%20age. Date of access: 2 October 2011.
Engelbrecht, B. & Crisp, N.2010. Improving the performance of the health system : perspectives on a national health insurance. South African health review. 195-204. Available: http://www. sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CC0QFjAA&url=
http%3A%2F%2Freference.sabinet.co.za%2Fwebx%2Faccess%2Felectronic_journals%2Fhealt hr%2Fhealthr_2010_a23.pdf&ei=JvloUpCBAajk4wS5p4H4Ag&usg=AFQjCNHYKuxFHY2k34mJ MjyGOyk2bpdUmQ. Date of access: 17 May 2011.
Epilepsy South Africa. 2011. Facts about epilepsy. Available:
http://www.epilepsy.org.za/facts/index.php. Date of access: 5 October 2011.
Erwin, W.G. 1991. The definition of drug utilization review: statement of issues. Clinical
Pharmacology & Therapeutics, 50(2):596-599.
Etminan, M. & Samii, A. Pharmacoepidemiology: A review of pharmacoepidemiologic study designs. Pharmacotherapy, 24(8):964-9.
Ettinger, A.B., Copeland, L.A., Zeber, J.E., Van Cott, A.C. & Pugh, M. 2010. Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals? Epilepsy &
behavior, 17(1):70-74.
Eurostat. 2012. Glossary. Arithmetic Means. Available:
http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Glossary:Arithmetic_average. Date of access: 21 September 2013.
Faden, L., Vialle-Valentin, C., Ross-Degnan, D. & Wagner, A. 2010. Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence. Health Policy, 100(2-3):134-43.
Farabaugh, A.H., Locascio, J.J., Yap, L., Weintraub, D., McDonald, W.M., Agoston, M., Alpert, J.E., Growdon, J. & Fava, M. 2009. Patterns of depressive symptoms in Parkinson’s disease.
362
Farabaugh, A., Locascio, J.J., Yap L., Growdon, J., Fava, M., Crawford, C., Matthews, J., McCutchen, J., Buchin, J.,Pava, J. and Alpert, J.E. 2010. Cognitive-behavioral therapy for patients with Parkinson’s disease and comorbid major depressive disorder. Psychosomatics, 51(2)124-9.
Fisher, R.S., Van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P. & Engel, J. 2005. Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia, 46(4):470-2. FDA. 2010. Information on drugs. Available: http://www.fda.gov/Drugs/InformationOnDrugs/ ucm079436.htm. Date of access: 23 September 2011.
Ford, E.S. & Chaoyang , L. 2008. Metabolic syndrome and health-related quality of life among U.S. adults. Annals of epidemiology,18:165-71.
Fountoulakis, K.N., Grunze, H., Panagiotidis P. & Kaprinis, G.2008. Treatment of bipolar depression: an update. Journal of affective disorders,109:21-34.
Franconi, F., Brunelleschi, S., Steardo, L. & Cuomo, V. 2007. Gender differences in drug responses. Pharmacological research, 55(2): 81-95.
Franklyn, J.A. 2009. Hypothyroidism. Medicine, 37(8):426-29.
Freid, V.M., Bernstein, A.B. & Bush, M.A. 2012. NCHS Data brief. Multiple chronic conditions among adults aged 45 and over: Trends over the past 10 years. Available:
http://www.cdc.gov/nchs/data/databriefs/db100.htm. Date of access: 19 December 2012. Gale Encyclopedia of Medicine. 2008. Chronic. Available:
http://medical-dictionary.thefreedictionary.com/chronic. Date of access: 10 March 2010.
Gama, H. 2008. Drug utilization studies. Arquivos de medicina, 22(2/3). Available:
http://www.scielo.oces.mctes.pt/pdf/am/v22n2-3/22n2-3a06.pdf. Date of access: 9 January 2012.
Garrison, L.P., Neumann, P.J., Erickson, P. & Marshall, D. 2005. Using real world data for coverage and payment decisions: the ISPOR real world data task force report. Available: http://www.ispor.org/workpaper/RWD_TF/RWTFManuscript.pdf. Date of access: 15 June 2012. Gellad, W.F., Choudry, N.K., Friedberg, M.W., Brookhart, M.A., Haas, J.S. & Shrank, W.H. 2009. Variation in drug prices at pharmacies: Are prices higher in poorer areas? Health services
363
Generic Pharmaceutical Association. 2011. Savings: an economic analysis of generic drug usage in the U.S. Available:
http://www.gphaonline.org/about-gpha/about-generics/case/generics-providing-savings-americans. Date of access: 5 December 2011. George, G., Quinlan, T. & Reardon, C. 2009. Human resources for health: A needs and gaps analysis of HRH in South Africa. Health economics and HIV & AIDS research division. Available:
http://www.sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCgQFjAA&url=http%3A% 2F%2Fwww.heard.org.za%2Fdownloads%2Fhuman-resources-for-health--a-needs-and-gaps-analysis-of-hrh-in-southafrica.pdf&ei=XU5iUqOuDMbt4gT36YGACA&usg=
AFQjCNHLbgZZ6Y2lhqciqP1u84gxadfTSw. Date of access: 8 March 2012.
Gerich, J.E. 2007. Type 2 diabetes is associated with multiple cardio metabolic risk factors.
Clinical cornerstone, 8(3):53-68.
Gibbon, C.J. 2003. South African medicines formulary. Cape Town: The South African medical association.
Goldman, D.P.,Joyce, G.F.,Escarce, J.J.,Pace, J.E., Solomon, M.D.,Laouri, M.,Landsman, P.B. & Teutsch, S.M. 2004. Pharmacy benefits and the use of drugs by the chronically ill. Journal of
the American medical association, 291(19): 2344-50.
Goldston, K. & Baillie, A.J. 2008. Depression and coronary heart disease: A review of the epidemiological evidence, explanatory mechanisms and management approaches. Clinical
psychology review, 28(2):288-306.
Gordon, C., Li, C.K. & Isenberg, D.A. 2009. Systemic lupus erythematosus. Medicine, 38(2):73-80.
Grabowski, H. & Mullins, D. 1997. Pharmacy benefit management, cost effectiveness analysis and drug formulary decisions. Social science & medicine, 45(4):535-44.
Gray, A. & Matsebula, T. 2003. Drug pricing – Chapter 9. Available:
http://www.healthlink.org.za/uploads/files/chapter9_00.pdf. Date of access; 29 September 2013. Green, R. What is Asthma? Western Cape Government. Available:
http://www.westerncape.gov.za/general-publication/what-asthma. Date of access : 19 November 2012.
Griffin, J.P. 2004. Venetian treacle and the foundation of medicines regulation. British journal of
364
Grippoa, A.J. & Johnson, A.K. 2002. Biological mechanisms in the relationship between depression and heart disease. Neuroscience and biobehavioral reviews, 26(8):941-62. Hall, E. & Erasmus, J. 2003. Medical practitioners and nurses. In: Human resources
development review 2003: Education, employment and skills in South Africa. Cape Town:
HSRC Press: 522-53.
Hanania, N.A. 2007. Revisiting asthma control: How should it be best defined? Pulmonary
Pharmacology & Therapeutics, 20(5):483-92.
Hart, A.L. & Siew, C. 2011. Crohn’s disease: review article. Medicine, 39(4):229-36.
Harris, B., Goudgea, J., Atagubab, J.E., McIntyreb, D., Nxumaloa, N., Jikwanac, S. & Chersich, M. 2011. Inequities in access to health care in South Africa. Journal of public health policy, 32(1):102-23.
Harrison, D. 2010 An overview of health and health care in South Africa 1994-2010: Priorities, progress and prospects for new gains. Muldersdrift. Available: http://www.doh.gov.za/
docs/reports/2010/overview1994-2010.pdf. Date of access: 29 January 2011.
Hasnain, M., Vieweg, V.R., Lesnefsky, E.J. & Pandurangi, A.K. 2010. Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines. Journal of
Psychosomatic research, 71(1):6-12.
Hay, C.R.M. Acquired Hemophilia. 1998. Baillire’s clinical haematology, 1(2):287-303.
Health Economics Unit. 2009. The public-private health sector mix in South Africa. University of Cape Town.
Health Systems Trust. 2012a. Health statistics – indicator data. Available:
http://indicators.hst.org.za/healthstats/112/data. Date of access: 15 September 2012. Health Systems Trust. 2012b. Medical scheme coverage. Available:
http://indicators.hst.org.za/healthstats/77/data/geo. Date of access: 15 September 2012. Health Systems Trust. 2012c. Population: % by province. Available:
http://indicators.hst.org.za/healthstats/3/data. Date of access: 15 September 2012. Heikkilä, R., Mäntyselkä, P., Hartikainen-Herranen, K. & Ahonen, R. 2007. Customers’ and
physicians’ opinions of and experiences with generic substitution during the first year in Finland.
365
Hennessy, S.,Bilker, W.B., Zhou, L.,Weber, A.L.,Brensinger, C.,Wang,Y. & Strom, B. 2003. Retrospective drug utilization review, prescribing errors, and clinical outcomes. Journal of the
American medical association, 290(11): 1494-9.
Hepler, C.D. & Strand, L.M. 1990. Opportunities and responsibilities in pharmaceutical care.
American journal of hospital pharmacists, 47(3):533-4.
Hess, L.M ., Raebel, M.A ., Conner, D.A. & Malone, D.C. 2006. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred
measures. Annals of pharmacotherapy, 40(7-8):1280-8.
Hirschfeld, M.A. Screening for Bilpolar Disorder. American journal of managed care, 13:S164-S169.
HIV/AIDS Services Administration. 2009. Health annals. Available: www.hasa.co.za/ media/uploads/about/.../HASA_Annals_1_56.pdf. Date of access: 17 August 2012.
Ho, M., Magid, D.J., Shetterly, S.M., Olson, K.L., Maddox, T.M., Peterson, P.M., Masoudi, F.A. & Rumsfeld, J.S. 2008. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. American heart journal, 155(4):772-9. Hofman, K.J. & Tollman, S.M. 2010. Health policies and practice: setting priorities for health.
South African medical journal, 100(12):798-800.
Hoffman, J.M., Li, E., Doloresco, F., Matusiak, L., Hunkler, R.J., Shah, N.D., Vermeulen, L.C. & Schumock, T. 2012. Projecting future drug expenditures. American journal of health-system
pharmacists, 69(5):405-21.
Hohman, J. A. 2006. International health care systems primer. The American medical student
association. Available: http://www.amsa.org/AMSA/Libraries/Committee_Docs/
IHSprimer.sflb.ashx. Date of access: 12 February 2011.
Hospital Association of South Africa. 2009. Private Hospital Review 2008. Available: http://www.hasa.co.za/downloads/HTG_Report.pdf. Date of access: 12 April 2011. Howell, D.C. 2008. Chi-square test – analysis of contingency table. Available:
http://www.uvm.edu/~dhowell/methods8/Supplements/ChiSquareTests.pdf. Date of access: 10 September 2013.
Hugtenburg, J.G., Blom, G. & Kisoensingh, S.U. 2005. Initial phase of chronic medication use; patients’ reasons for discontinuation. British journal of clinical pharmacology, 61(3):352-4.
366
Hyperdictionary. 2013. Definition of frequency. Available:
http://www.hyperdictionary.com/dictionary/frequency. Date of access: 20 September 2013. IMS.2010a. IMS forecasts global pharmaceutical market growth of 5-8% annually through 2014; maintains expectations of 4-6% growth in 2010. Available:
http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vg nextoid=4b8c410b6c718210VgnVCM100000ed152ca2RCRD. Date of access: 10 July 2010. IMS. 2010b. IMS market prognosis 2010-2014 South Africa. IMS Health.7 Harewood
Avenue,London.
IMS. 2011a. Market prognosis report 2010-2014. Available:
http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Market_Prognosis1 .pdf. Date of access: 4 April 2011.
IMS. 2011b. IMS announces 17 countries now rank as high-growth ‘pharmerging’ markets; forecast to contribute nearly half of industry growth by 2013.
http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vg nextoid=01624605b5367210VgnVCM100000ed152ca2RCRD. Date of access: 14 May 2010 IMS.2012a. The global use of medicines: outlook through 2016. Available:
http://www.imshealth.com/deployedfiles/ims/Global/Content/Insights/IMS%20Institute%20for%2 0Healthcare%20Informatics/Global%20Use%20of%20Meds%202011/Medicines_Outlook_Thro ugh_2016_Report.pdf. Date of access: 5 September 2012.
IMS. 2012b. Total private market data South Africa. Report from available IMS data. Restricted access for users only.
Ismail, K. 2009. Depression and diabetes. Psychiatry, 8(6):203-7.
Jackson, R.A. 1981. Selected statistical procedures. (In Nelson, A.A. ed. Research In pharmacy practice: principles and methods. Bethesda, Md: American Society of Hospital Pharmacists. p. 99-106).
Järvinen, T.L.N., Sievänen, H., Kannus, P., Jokihaara, J. & Khan, K.M. 2011. The true cost of pharmacological disease prevention. British medical journal, 342(d2175):1-5
Jesson, J.K. & Wilson, K.A. 2003. One stop health centres: what co-location means for pharmacy. Health & place, 9(1):253-61.
367
Johnson, S.K. & Natelson, B. 1996. Depression in fatiguing illness: Comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. Journal of affective disorders, 39(1):21-30.
Johnsrud, M. 2006. Will a mandatory mail order pharmacy benefit save payers money? Investigating the evidence. The center for pharmacoeconomic studies. Available:
http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=12192. Date of access: 4 June 2009. Joppe, M. 2000. The research process. Journal of industrial teacher education,
32(3). Available: http://www.ryerson.ca/~mjoppe/rp.htm. Date of access: 12 February 2009. Kaiser Family Foundation/Harvard School of Public Health. 2008. The public on prescription drugs and pharmaceutical companies. Available: http://kff.org/health-costs/poll-finding/usa-todaykaiser-family-foundationharvard-school-of-public/. Date of access: 16 May 2010.
Karve, S., Cleves, M.A., Hudson, T.J., West, D.S. & Martin, B.C. 2009. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value in health, 12(6):989-95.
Kavanaugh, A. 2007. Economic consequences of established rheumatoid arthritis and its treatment. Best practice & research clinical rheumatology, 21(5):929-42.
Kirking, D.M., Ascione, F. & Richards, W.J. 2007. Choices in prescription-drug benefit programs: Mail versus community pharmacy services. The Milbank quarterly, 68(1):29-51. Kleinert, S. & Horton, R. 2009. South Africa’s health: departing for a better future? The lancet, 374(9692):759-60.
Knapp, D.A., Brandon, B.N., West, S. & Leavitt, D.E. 1973. Drug use review: A manual system.
Journal of the American pharmaceutical association, 13(8):417-21.
Kohout, F.J. & Norwood, G.J. 1981. Analysis of variance. (In Nelson, A.A. ed. Research in pharmacy practice: principles and methods. Bethesda: American society of hospital pharmacists: p.114-20).
Kotwani, A. 2010. Access to essential medicines and standard treatment for chronic diseases.
Indian Journal of Pharmacology. 42(3):127-8.
Kovacs, A.H., Saidi, A.S., Kuhl, E.A., Sears, S.F., Silversides, C., Harrison, J.L., Ong, L., Colman, J., Oechslin, E. & Nolan, R.P. 2009. Depression and anxiety in adult congenital heart disease: predictors and prevalence. International journal of cardiology, 137(2):158-164.
368
KPMG. 2011. Funding NHI: An economic analysis of the NHI. Available:
http://www.kpmg.com/ZA/en/IssuesAndInsights/ArticlesPublications/General-Industries-Publications/Documents/KPMG%20NHI%20Economic%20Impact%20Research%20brochure.p df. Date of access: 14 November 2011.
Kung, H.C., Hoyert, D.L., Xu, J.Q. & Murphy, S.L. 2005. Deaths: final data for 2005. National vital statistics reports. Available: http://www.cdc.gov/nchs/dashrankta/nvsr/nvsr56/
nvsr56_10.pdf. Date of access: 15 March 2008.
Kuzuya, T., Nakagawa, S., Satoh, J., Kanazawa, Y., Iwamoto, Y., Kobayashi, M., Nanjo, K., Sasaki, A., Seino, Y., Ito, C., Shima, K., Nonaka, K. & Kadowaki, T. 2002. Committee of the Japan diabetes society on the diagnostic criteria of diabetes mellitus. Diabetes research and
clinical practice, 55(1):65-85.
Leedy, P.D. & Ormrod, J.E. 2010. Practical research planning and design. 9th ed. Boston: Pearson.
Liberman, J.N., Hutchins, D.S., Shrank, W.H., Slezak, J. & Brennan, T.A. 2011. Adherence to medication under mandatory and voluntary mail benefit designs. American journal of managed
care, 17(7):260-9.
Lind, D.A. & Mason, R.D. 1997. Basic statistics for business and economics. 2nd ed. Chicago: Irwin.
Litvak, E. & Bisognano, M. 2011. More patients, less payment: Increasing hospital efficiency in the aftermath of health reform. Health affairs, 30(1):76-80.
Lowe, R.F. & Montagu, D. 2009. Legislation, regulation, and consolidation in the retail pharmacy sector in low-income countries. Southern med review, 2(2):35-44.
Luo, X., Doherty, J., Cappelleri, J.C. & Frush, K. 2007. Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics. Current medical research and opinion, 23(11):2607-15.
Lutchman, D. 2011. Pharmaeconomics and the clinician: A South African perspective. South
African family practice, 92(53):92.
Mahlangu, J. & Gillham, A. 2008. Treatment Guidelines for Haemophilia. South African medical
369
Manikandan, S. 2011. Measures of central tendency: The mean. Journal of pharmacology and
pharmacotherapy. 2(2):140-2.
Mann, C.J. 2003. Research design II: cohort, cross sectional and case control studies.
Emergency medicine journal, 20(1):54-60.
Mant, J., Al-Mohammad, A., Swain, S. & Laramee, P. 2011. Guideline development group. Management of chronic heart failure in adults: Synopsis of the national institute for health and clinical excellence guideline. Annals of internal medicine, 155(4):252-9.
Marczyk, G., Dematteo, D. & Festinger, D. 2005. Essentials of research design and methodology. Hoboken, New Jersey: John Wiley & Sons.
Marketing Research and Information Systems. 2006. Chapter 1: Role of marketing research. Available: http://www.fao.org/docrep/W3241E/w3241e02.htm#TopOfPage. Date of access: 7 April 2008.
Marmor, T. & Wendt, C. 2012. Conceptual frameworks for comparing healthcare politics and policy. Health policy, 107(1):11-20.
Matesebula, T. & Willie, M. 2007. SAHR: Private hospitals. Available:
www.hst.org.za/uploads/files/SAHR2007.pdf. Date of access: 4 August 2012.
Mathemetics and Statistics Dictionary. 2013. Definition of ANOVA (analysis of variance). Available: http://mathematicsandstatistics.science- dictionary.org/Dictionary-of-Common-Concepts-in-Statistics/ANOVA_(analysis_of_variance). Date of access: 11 September 2013. Mayo Clinic. 2011. Lupus. Available: http://www.mayoclinic.com/health/lupus/DS00115. Date of access: 28 September 2013.
Mayo Clinic. 2012a. Addison’s Disease. Available: http://www.mayoclinic.com/health/addisons-disease/DS00361. Date of access: 18 September 2013.
Mayo Clinic. 2012b. Parkinson’s Disease. Available: http://www.mayoclinic.com/health/ parkinsons-disease/DS00295. Date of access: 28 September 2013.
Mayosi, B.M., Fisher, A.J., Lalloo, U.G., Sitas, F., Tollman, M. & Bradshaw, D. 2009. The burden of non-communicable diseases in South Africa. The lancet , 374: 934–47.
MCC. 2008. General information. Available: http://www.kznhealth.gov.za/research/mccinfo.pdf. Date of access: 19 April 2012.
370
McDonald, J.H. 2009. Handbook of Biological Statistics. 2nd ed. Baltimore, Maryland: Sparky House Publishing. Available: http://udel.edu/~mcdonald/statintro.html#further. Date of access: 4 March 2010.
McFadden, D.W., Calvario, E. & Graves, C. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy. Journal of surgical research, 40(1):1-5.
McHorney, C.A., Spain, V., Alexander, C.M. & Simmons, J. 2009. validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clinical therapeutics, 31(11): 2584-607.
McIntyre, D., Bloom, J., Doherthy, J & Brijal, P. 1995. Health expenditure and finance in South Africa. Health Systems Trust and the World Bank. Available:
http://www.hst.org.za/uploads/files/hstefsa.pdf. Date of access: 19 September 2009. McIntyre, D. & Thiede, M. 2007. Health care financing and expenditure. (In: Bhana, R., Harrison, S. & Ntuli, A. eds. South African Health Review. Durban: Health Systems Trust. Available: http://www.hst.org.za/uploads/files/sahr05_chapter10.pdf. Date of access: 9 March 2011).
McLeod, H. 2007. Framework for post-retirement protection in respect of medical scheme contributions. In: Department of Social Development. Reform of retirement provisions: feasibility studies. Pretoria.
McLeod, H. 2009. The impact of chronic disease on a future NHI. Available: http://www.imsa.org.za/.../. Date of access: 23 September 2012.
Media Resource Desk. 2008. Drug patents and their implications on access to anti-retroviral therapy. Available: http://www.mediaresourcedesk.org/factSheets/
Drug%20Patents%20and%20their%20implications%20on%20
access%20to%20Antiretroviral%20Therapy.htm. Date of access: 9 June 2008. Medhi, J. 1992. Statistical methods: An introductory text. New York: Wiley.
MediKredit. 2013. National pharmaceutical product index (NAPPI) product suite. Available: https://www.medikredit.co.za/index.php?option=com_content&view=article&id=21&Itemid=31. Date of access: 12 August 2013.
371
Mediscor. 2012. Mediscor PBM. Available: http://www.mediscor.net/aboutus.html. Date of access: 17 June 2012.
Medline Plus. 2011. Diabetes Insipidus. Available: http://www.nlm.nih.gov/medlineplus/ency/ article/000377.htm. Date of access: 25 September 2013.
Medline Plus. 2012. Heart failure-overview. Available:
http://www.nlm.nih.gov/medlineplus/ency/article/000158.htm. Date of access: 8 February 2012. Medline Plus. 2013. Acute vs. chronic conditions. Available: http://www.nlm.nih.gov/
medlineplus/ency/imagepages/18126.htm. Date of access: 12 May 2013. MEDpages. 2011. Medical: Statistics (September 2011). Available:
http://www.medpages.co.za/sf/index.php?page=stats. Date of access: 11 October 2011. Menza, M., Dobkin, R.D., Marin, H., Mark, M., Gara, M., Buyske, S., Bienfait, K. & Dicke, A. 2009. The impact of treatment of depression in quality of life: Disability and relapse in patients with Parkinson’s disease. Movement disorders, 24(9):1325-32.
Mikeal, R.L., Brown, T.P., Lazarus, H.L. & Vinson, M.C. 1975. Quality of pharmaceutical care in hospitals. American journal of hospital pharmacy, 32(6):567-74.
Milton, J.G. 2010. Epilepsy as a dynamic disease: A tutorial of the past with an eye to the future.
Epilepsy and behavior, 18:33-44.
Misra, N. & Cele, C. 2007. “Band-aids” and bargaining chambers –the HR crisis viewed from the pharmacy manager’s position. South African pharmaceutical journal, Sep. 44-46.
Mitton, J. 2000. The sociological spread of HIV/AIDS in South Africa. Journal of the association
of nurses in AIDS care, 11(4):17-26.
Moczygemba, L. R., Barner J.C., Brown, C.M., Lawson,K.A., Gabrillo, G.P. & Johnsrud, M. 2010. Patient satisfaction with a pharmacist-provided telephone medication therapy
management program. Research in social and administrative pharmacy, 6:143-54.
Mori, A.T. & Robberstad, B. 2012. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: A systematic review. Available:
http://www.biomedcentral.com/1472-6947/12/110. Date of access: 19 October 2012.
Morgan S.G. 2005. Booming prescription drug expenditure: A population-based analysis of age dynamics. Medical care, 43(10):996-1008.
372
Motheral, B.R. & Fairman, K.A. 1997. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clinical therapeutics, 19(2):346-66.
Motheral, B., Brooks, J., Clark, M.A., Crown, W.H., Davey, P., Hutchins, D., Martin, B.C., Stang P. 2003. A checklist for retrospective database studies-report of the ISPOR task force on retrospective databases. Value in health, 6(2):90-7.
Motheral, B.R. & Heinle, S.M. 2004. Predictors of satisfaction of health plan members with prescription drug benefits. American journal of health-system pharmacy, 15(61):1007-14. Murray, C., Gakidou, E. & Frenk, J. 2000. health inequalities in the African regions of the world.
Health organization bulletin of the World Health Organization, 78(2):234-35. Available:
http://apps.who.int/iris/bitstream/10665/1827/1/9789290231660.pdf. Date of access: 12 September 2010.
Nandy, K. 2012. Understanding and quantifying effect sizes. Available: http://nursing.ucla.edu/ workfiles/research/Effect%20Size%204-9-2012.pdf. Date of access: 24 September 2013. National Academy of an Aging Society. 1999. Chronic conditions: A challenge for the 21st century. Available: http://www.agingsociety.org/chronic.pdf. Date of access: 4 March 2011. National Diabetes Fact Sheet. 2007. Department of health and human services: centres for disease control and prevention, Atlanta, GA: U.S. Available:
http://www.cdc.gov/Diabetes/pubs/factsheet07.htm. Date of access: 22 April 2011. National US Eye Institute. 2012. Facts about glaucoma. Available:
http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp. Date of access: 17 August 2012. National Heart, Lung and Blood Institute. 2012. What is cardiomyopathy? Available:
http://www.nhlbi.nih.gov/health/health-topics/topics/cm/. Date of access: 26 September 2013. National Kidney Foundation. 2013. About kidney disease. Available:
http://www.kidney.org/kidneydisease/aboutckd.cfm. Date of access: 26 September 2013. National Treasury.2010. National Budget Review – Social Security and Health Care Financing, Pretoria: Department: National Treasury, Republic of South Africa, 2010.
Navarro, R. 2008. Managed Care Pharmacy Practice. 2nd ed. Jones & Bartlett Learning.
Nelson, A.A. 1981. Measurement, reliability, validity. (In Nelson A.A., ed. Research in Pharmacy Practice: principles and methods. Bethesda, Md: American Society of hospital Pharmacists. p. 37-48).
373
Neuman, W. 1997. Social research methods: Qualitative and quantitative approaches (3
rd
ed.). Needham Heights, MA: Allyn & Bacon.
New Clicks Holdings. 2011. Manager’s presentation. Available:
http://www.ecampaigns.co.za/clicksgroup/ManagementPresentation10-2011.pdf. Date of access: 7 December 2011.
New York State Indicators. 2007. Demographic data terms. Available:
http://www.nyskwic.org/u_data/demo_data_terms.cfm. Date of access: 27 July 2007. NDIC. 2007. Diabetes Overview. Available:
http://diabetes.niddk.nih.gov/dm/pubs/overview/index.aspx. Date of access: 16 July 2011. Niederlaender, E. 2006. Statistics in focus: population and social conditions. Available: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-NK-06-010/EN/KS-NK-06-010-EN.PDF. Date of access: 10 January 2011.
Nilsson, J.L.G. & Melander, A. 2000. Use of generic drugs and effects of the reference price system in Sweden. Drug information journal, 34(4):1195-200.
NIST/SEMATECH. 2012. e-Handbook of Statistical Methods. Available: http://www.itl.nist.gov/ div898/handbook/ prc/section4/prc43.htm. Date of access: 8 September 2013.
Nolte,E. & McKee, M. 2008. Caring for people with chronic conditions: A health system perspective. Open University Press. Available: http://www.euro.who.int/__data/assets/ pdf_file/0006/96468/E91878.pdf. Date of access: 23 October 2013.
Norman, R., Bradshaw, D., Schneider, M., Pieterse, D. & Groenewald, P. 2006. Revised burden of disease estimates for the comparative risk factor assessment. Cape Town: South African Medical Research Council.
Nuijten, M.J.C. & Hutton, J. 2002. Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis. Value in health, 5(1):44-5.
Odgen, C.L., Carroll, M.D., McDowell, M.A. & Flegal, K.M. 2007. Obesity among adults in the United States: no change since 2003-2004. National center for health statistics: NCHS data brief no 1. Available: http://www.cdc.gov/nchs/data/databriefs/db01.pdf. Date of access: 9 January 2011.
374
Odgen, C.L., Caroll, M.D., Curtin, L., Lamb, M.M. & Flegal, K. 2010. Prevalence of high body mass index in US children and adolescents, 2007–2008. Journal of the American medical
association, 303(3):242-9.
O’Halloran, J., Miller, C. & Britt, H. 2004. Defining chronic conditions for primary care with ICPC-2. Family practice, 21(4):381-6.
Okunade, A.A. & Suraratdecha, C. 2006. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries. Social science and medicine, 63(4):225-38.
Oxford Dictionary. 2010. Chronic. Available: http://oxforddictionaries.com/view/entry/ m_en_gb0148340#m_en_gb0148340. Date of access: 5 June 2011.
Panacek, E.A. & Thompson, C.B. 1995. Basics of research (part 3): Research study design. Air
medical journal, 14(3):139-46.
Park, A. 2009. Hyperlipidaemia. Medicine, 37(9):497-499.
Patel, A., Gauld, R., Norris, P. and Rades, T. 2012. Quality of generic medicines in South Africa: Perceptions versus reality – A qualitative study. BMC health services research, 12:297.
Available: http://www.biomedcentral.com/1472-6963/12/297. Date of access: 28 September 2013.
Peterson, A.M., Nau, D.P., PhD, Cramer, J.A., Benner, J.,Gwadry-Sridhar,F. & Nichol, M.2007. A checklist for medication compliance and persistence studies using retrospective databases.
Value in health, 10(1):3-12.
Pearmin, D. 2000. South African health review 2000: Briefing summary. Available: http://www.hst.org.za/sahr. Date of access: 10 January 2011.
Peltzer, K. 2009. Patient experiences and health system responsiveness in South Africa. BMC
health services research, 9(1/2). Available: http://www.biomedcentral.com/1472-6963/9/117.
Date of access: 30 September 2012.
Peuskens, J. 2004. Clinical effectiveness with chronic schizophrenia. European
neuropsychopharmacology, 14(0):453-9.
PIASA. 2011. Central role of medicines in healthcare delivery: PIASA comments on NHI green paper. Available: http://www.mm3admin.co.za/documents/docmanager/2D5ED792-878C-4371-9575-8281A96BBB26/00023911.pdf. Date of access: 14 June 2012.
375
Piette, J.D., Heisler, M., & Wagner, T.H. Cost-Related Medication Underuse Among Chronically III Adults: the Treatments People Forgo, How Often, and Who Is at Risk. American Journal of
Public Health, 94(10): 1782-7.
Pillay,V. 2010. ANC aims to implement NHI in 2012. Mail and Guardian, 21 September. Pick n Pay Holdings. 2011. Pick n Pay Results Presentation. Available: http://www.picknpay-ir.co.za/downloads/PnP_Results_presentation_2011.pdf. Date of access: 8 December 2011. Pittman, D.G., Chen, W., Bowlin, S.J. & Foody,J.M. 2011. Adherence to tsatins, subsequent healthcare costs, and cardiovascular hospitalizations. American journal of cardiology, 6(107): 1662-6.
Powell, K.M. & Edgren, B. 1995. Failure of educational videotapes to improve medication
compliance in a health maintenance organization. American journal of health-system Pharmacy, 52:2196-9.
Power, J.D. 2008. Flat-rate pricing for generic prescriptions may lead to higher satisfaction among pharmacy customers. Available: http://content1.businesscenter.jdpower.com/ JDPAContent/CorpComm/News/content/Releases/pdf/2008198.pdf. Date of access: 8 December 2011.
Price Waterhouse Coopers’ Health Research Institute. 2010. Behind the numbers: medical cost trends for 2010. http://pwchealth.com/cgilocal/hcregister.cgi?link=reg/
Behind_the_numbers_Medical_cost_trends_for_2010.pdf. Date of access: 17 June 2011. Puig-Junoy, J. 2007. The impact of generic reference pricing interventions in the statin market.
Health policy, 84(1):14-29.
Reipert, B. 2004. Multiple sclerosis: a short view of the disease and its differences between men and women. Journal of Men’s Health and Gender, 1(4):334-40.
Research Methods Knowledge Base. 2006. Research Design. Available:
http://www.socialresearchmethods.net/kb/destypes.php. Date of access: 4 April 2008. Richardson, J. 2003. PBMs: The Basics and an Industry Overview. The Health Strategies Consultancy, LLC. Available: http://www.ftc.gov/ogc/healthcarehearings/docs/
376
Riu, F.R., Vert, I.S., Martı´n, A.L., Gonza´lez, R.R. & Salab, A.S. 2003. A prospective study of cardiovascular disease in patients with type 2 diabetes: 6.3 years of follow-up. Journal of
Ddabetes and its complications, 17(5):235-42.
Roe, C.M., McNamara, A.M & Motheral, B.R. 2002. Use of chronic medications among a large, commercially-insured US population. Pharmacoepidemiology and drug safety, 11(4):301-9. Roland Berger Strategy Consultants. 2007. Trends in European health care: How to create value in a dynamic environment. http://www.rolandberger.com/media/pdf/rb_press/
RB_Trends_in_European_healthcare_20070901.pdf. Date of access: 10 August 2010. SADAG. 2011. Bipolar disorder treatment and referral guide. Available:
http://www.sadag.org/bipolar?gclid=CJmtuYj8uKsCFUFLpgodgBpZeQ. Date of access: 25 September 2011.
Santana, S., Lausen, B., Bujonwska-Fedak, M., Chronaki, C., Kummervold, P.E., Rasmussen, J. & Sorensen, T. 2010. Online communication between doctors and patients in Europe: Status and perspective. Journal of Medical Internet Research, 12(2). Available:
http://www.jmir.org/2010/2/e20. Date of access: 18 September 2010.
SAPC. 2008. South African Pharmacy Council Annual Report. Available: http://www.e2.co.za/ emags/SAPCAnnualReport2008/pageflip.html. Date of access: 14 August 2010.
SAPC. 2011. Statistics: Registered Organizations by Sector.
http://www.pharmcouncil.co.za/B_Statistics.asp Date of access: 23 April 2012.
SAPC, 2013. Press Release, First National Pharmacy Conference 23-26 June 2013. Available: http://www.sapcconference.za.org/news. Date of access: 19 February 2014.
Sarafino, E.P. 2005. Chapter 7: Single-factor, independent-groups designs. Available:
http://www.prenhall.com%2Fwps%2Fmedia%2Fobjects%2F1755%2F1797527%2Fsarafino_cha p07.ppt&ei=uT1cUsToL6mM0AW1uIGwAg&usg=AFQjCNEkXWaWZo1sT9P653JzoYL0pZyFpw &sig2=RVGkxMhuOK0b2QSO2STEeg. Date of access: 27 September 2013.
SARS. 2011. Tax guide on the deduction of medical, physical impairment and disability expenses: Issue 3. Available: http://www.sars.gov.za/AllDocs/OpsDocs/Guides/LAPD-IT-G07%20-%20Guide%20on%20Deduction%20of%20Medical%20Physical%20Impairment% 20and%20Disability%20Expenses%20-%20External%20Guide.pdf. Date of access: 11 June 2011.
377
Scahill, S.L., Harrison, J. & Carswell, P. 2010. What constitutes an effective community pharmacy? – Development of a preliminary model of organizational effectiveness through concept mapping with multiple stakeholders. International journal for quality in health care, 22(4):324-32.
Schaay, N. & Sanders, D. 2008. International perspective on primary health care over the past 30 Years. (In Barron, P. & Roma-Reardon, J. eds. South African Health Review 2008. Durban: Health Systems Trust. p. 1-16).
Schaay, N., Sanders, D. and Kruger, V. 2011. Overview of health sector reforms in South Africa. Available: http://www.sarrahsouthafrica.org/LinkClick.aspx?fileticket=
XB382Sl2kmw%3D&tabid=2321. Date of access: 17 August 2012.
Schellak, N., Gous, A.G.S. 2011. Proposing a clinical referral system in a resource limited setting: Introducing a pharmaceutical care score sheet for the Neonatal Intensive Care Unit (NICU) in South Africa. Available: http://www.sasocp.co.za/downloads/conference/D2-P7-%20Referral%20Score%20Sheet%20in%20Pharmacy.pdf. Date of access : 12 March 2014. Schlotzhauer, S.D. and Littell, R.C. 1997. SAS system for elementary statistical analysis. 2nd ed. North Carolina: SAS Institute.
Schussler, A. 2008. Inflation, costs and comparisons of hospital services in South Africa. Available: www.hasa.co.za/media/...01.../Inflation_Cost_and_Comparisons.pdf. Date of access: 28 September 2012.
Seedat, Y. and Rayner, B.L. 2012. University South Africa: hypertension guideline. South
African Medical Journal, 102(1):57-84.
Serfontein, J.H.P. 1989. Medisyneverbruik in provinsiale hospitale met besondere verwysing na die rol van die apteker in die beheer proses. PhD dissertation. Potchefstroom: NWU.
Serfontein, JHP., Lubbe, M.S., Basson,W.D., John, G.K. & Adsetts, J. 2006. The availability of private vs. public pharmaceutical services in different geographical areas in South Africa.
Pharmaciae, 14(2):18.
Sergeant, J.A. & Kingston, W.W. 2005. Analyzing the true cost of delivering medications.
American journal of kidney diseases, 45(5):917-25.
Serna, M.C., Cruz, I., Real, J, Gascó, E. & Galván, L. 2010. Duration and adherence of
antidepressant treatment (2003 to 2007) based on prescription databases. European psychiatry, 25(4):206-13.
378
Shadid, J. 2010. Satisfaction of mail service and walk-in pharmacy patients in a university clinic outpatient setting. Journal of the American pharmacists association, 50(3):336.
Sharma, P., Sample, P.A., Zangwill, L.M. & Schuman, J.S. 2008. Diagnostic tools for glaucoma detection and management. Survey of opthalmology, 53(1):18-32.
Shiyanbola,O.O. & Farris,K.B. 2010. Concerns and beliefs about medicines and inappropriate medications: an internet-based survey on risk factors for self-reported adverse drug events among older adults. The American journal of geriatric pharmacotherapy, 8(3): 245-57. Sjöqvist, F. & Birkett, D. 2003. Chapter 10. Drug Utilization. Available:
http://www.iuphar.org/pdf/hum_76.pdf. Date of access : 25 March 2010. Shoprite Holdings. 2011. Integrated Report until June 2011.
http://www.sharedata.co.za/Data/000647/pdfs/SHOPRIT_ar_jun11.pdf. Date of access: 8 December 2011.
Shrank, W.H., Stedman, M., Ettner, S.L., DeLapp, D., Dirstine, J., Brookhart, M.A., Fischer, M.A., Avron, J. & Asch, S.M. 2007. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. Journal of internal medicine, 22(9):1298-304.
Shulman, R.M. & Daneman, D. 2010. Type 1 diabetes mellitus in childhood. Medicine, 38(12):679-85.
Sikka,R., Xia,F & Aubert,R.E. 2005. Estimating medication persistency using administrative claims data. The American journal of managed care, 11(7):449-457.
Smith, C. 2010. Choosing the right model vital for NHI success. News, 4 Nov. Available: http://www.medicalchronicle.co.za/choosing-the-right-model-vital-for-nhi-success/. Date of access: 14 November 2011.
Snyman, J.R. ed. 2009. MIMS monthly index of medical specialities. MIMS: Pretoria. Snyman, J.R. ed. 2013. MIMS monthly index of medical specialities. MIMS: Pretoria.
Soumerai, S.B. & Lipton, H.L. 1995. Computer-based drug utilization review: Risk, benefit or boondoggle? New England journal of medicine, 332(24):1641-5.
South Africa. 1998. Medical Schemes Act 131 of 1998.
South Africa. 2004. Amendments to the general regulation made in terms of the Medical Schemes Act, 1998 (Act no.131 of 1998). Prescribed minimum benefits. Government Gazette, 20061:407, 7 May.
379
South African Haemophilia Association. 2011. About Haemophilia. Available: http://www.haemophilia.org.za/about.html. Date of access: 10 September 2013.
Sowers, J.R., Epstein, M. & Frolich, E.D. 2001. Diabetes, hypertension and cardiovascular disease: an update. Hypertension, 37(4):1053-9.
Springer Reference. 2012. Direct Medical Costs. Available:
http://www.springerreference.com/docs/html/chapterdbid/82170.html. Date of access: 14 July 2013.
Statistics SA. 2008. Mortality and causes of death in South Africa, 2008: Findings from death notification. Available: http://www.statssa.gov.za/publications/P03093/P030932008.pdf. Date of access: 14 January 2012.
Statistics SA. 2011. General household survey 2010. http://www.statssa.gov.za/ publications/P0318/P0318June2010.pdf. Date of access: 10 October 2012.
Stats.Org. 2012. Statistics simplified. Available: http://stats.org/faq_type.htm. Date of access: 14 June 2012.
Stat Trek. 2012. Statistics and probability dictionary. Standard deviation. Available:
http://stattrek.com/statistics/dictionary.aspx?definition=standard_deviation. Date of access: 4 August 2012.
Stedman’s Medical Dictionary. 2013. Definition: Standard Error of the Mean. Available: http://www.drugs.com/dict/standard-error-of-the-mean.html. Date of access: 18 August 2013. Steiner, J.F. & Prochazka, A.V.1997. The assessment of refill compliance using pharmacy records: Methods, validity and applications. Journal of clinical epidemiology, 50(1):105-16. Steyn, H.S. 2009. Manual for the determination of effect size indices and practical significance. Chapter 4: Standardized differences. Available: http:/www.puk.ac.za/opencms/export/PUK/ html/fakulteite/natuur/skd/handleiding_e.html. Date of access: 8 October 2009.
Stoner, S.C., Marken, P.A. & Sommi, R.W. 1998. Psychiatric comorbidity and medical illness.
Medical update for psychiatrics, 3(3):64-70.
Strand, L.M., Cipolle, R. & Morley,P.C. 1992. Pharmaceutical care: An introduction. Current
concepts. Kalamazoo, MI: The Upjohn Company.
Strange, E.F., Travis, S.P.L., Vermeire, S., Reinisch, W., Geboes, K., Barakauskiene, A., Feakins, R., Fléjou, J., Herfarth, H., Hommes, D.W., Kupcinskas, L., Lakatos, P.L., Mantzaris,
380
G.J., Schreiber, S., Villanacci, V. & Warren, B.F. 2008. European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of
Crohn's and Colitis, 2(1):1-23
Stroupe, K.T., Teal, E.T., Tu, W., Weiner, M. & Murray, M.D. 2006. Association of refill
adherence and health care use among adults with hypertension in an urban health care system.
Pharmacotherapy, 26(6):779-89.
Superko, R.H. 1998. Did grandma give you heart disease?: The new battle against coronary artery disease. American journal of cardiology, 82(9A):34Q-46Q.
Tandon, R., Matcheri, S., Keshavan, B. & Henry, A. 2008. Schizophrenia, “Just the facts”: what we know in 2008. Schizophrenia research, 102(1-3):1-18.
Taniguchi, R. 1995. Pharmacy benefit management companies. American journal of
health-system pharmacy, 52(17):1915-7.
Tanner, M. 2008.The grass is not always greener. A look at national health care systems around the world. Policy analysis. 613 (3):1-48.
The Monitor Group. 2008. Health Systems Comparison Project, commissioned by Discovery Health (Pty) Ltd 2008. Johannesburg: Discovery Health (Pty) Ltd.
Theodorou, A.A. & Slezak, J. 2009. Factors affecting pharmacy trends in 2008. The American
journal of pharmacy benefits, 1(1):53-59.
Trivedi, A.N., Moloo, H. & Mor, V. 2010. Increased ambulatory care copayments and hospitalizations among the elderly. New England journal of medicine, 362:320-8.
Truter, I. 2008. A review of drug utilization studies and methodologies. Jordan journal of
pharmaceutical sciences, 1(2):91-104.
UNAIDS. 2005. Aids epidemic update 2005. Available:
http://www.unaids.org/en/media/unaids/contentassets/dataimport/publications/irc-pub06/epi_update2005_en.pdf. Date of access: 14 July 2011.
US Department of State. 2010. US Relations with South Africa. Available: http://www.state.gov/r/pa/ei/bgn/2898.htm. Date of access: 6 April 2011.
Van den Heever, A. 2010. Financial feasibility: review of NHI proposals for South Africa. SAHR. Pretoria.
381
Van Mourik. M.S.M., Cameron, A., Ewen, M., & Laing, R.O. 2010. Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC cardiovascular disorders, 10(25):1-9.
Van Stratena, A., Geraedtsta, A., Verdonck-de Leeuw, I., Andersson, G. & Cuijpersa, P. 2010. Psychological treatment of depressive symptoms in patients with medical disorders: A meta-analysis. Journal of psychosomatic research, 69(1):23-32.
Vanelli, M., Pedan, A., Liu, N., Hoar, J., Messier, D. & Kiarsis, K. 2009. The Role of Patient Inexperience in Medication Discontinuation: A Retrospective Analysis of Medication
Nonpersistence in Seven Chronic Illnesses. Clinical therapeutics, 31(11): 2628-52.
Vogenberg, F.R. 2001. Introduction to applied pharmacoeconomics. New York: McGraw-Hill. Vossa, W.D., Arnett, P.A., Higginsona, C.I., Randolpha, J.J. & Camposa, M.D. 2002.
Contributing factors to depressed mood in Multiple Sclerosis. Archives of neuropsychology, 17(2):103-15.
Vukmir, R.B. 1995. Cardiac arrhythmia diagnosis. American journal of emergency medicine, 13(2):204-210.
Wagner, A.K., Graves, A.J., Reiss, S. K., Lecates, R., Zhang, F. & Ross-Degnan, D. 2011. Access to care and medicines, burden of health care expenditures and risk protection: Results from the World Health survey. Health policy, 100(2-3):151-8.
Waitzfelder, B., Gerzoff, R.B., Karter, A.J., Crystal, S., Bair, M.J., Ettner, S.L., Brown, A.F., Subramanian, U., Luj, S., Marrero, D., Herman, W.H., Selby, J.V. & Dudley, R.A. 2010. Correlates of depression among people with diabetes: The translating research into action for diabetes (TRIAD) study. Primary care diabetes, 4(4):215-22.
Waning, B and Montagne, M. 2001. Pharmacoepidemiology: principles and practice. New York: McGraw-Hill.
Wertheimer, A. 1988. Quality control and drug utilization review. Pharmaceutisch weekblad
scientific edition, 10(4):154-7.
Wettermark, B., Vlahovic-Palcevski,V., Blix, H.S., Ronning, M.,van der Stichele, R.H. 2008. Chapter 7: Drug Utilisation Research. (In Pharmacoepidemiology and therapeutic risk
management. Hartzema, A.G., Tilson, H.H. & Chan, K.A. eds. Harvey Whitney Books Company, Cincinnati, OH, 45242).
382
Whitehead, M. 1992. The concepts and principles of equity and health. International journal of
health services, 22(3):429-45.
Wier, L.M. Henke, R. & Friedman, B. 2010. Diagnostic groups with rapidly increasing costs, by payer, 2001–2007. Available: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb91.pdf. Date of access : 28 February 2010.
WHO. 1948. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference. New York, NY.
WHO. 1998. Schizophrenia and public health. Available:
www.who.int/mental_health/media/en/55.pdf. Date of access: 26 October 2012. WHO. 2000. World Health Report 2000. Geneva: World Health Organization.
WHO. 2001. How to develop and implement a national drug policy. 2nd ed. Geneva: World Health Organization.
WHO. 2003a. Collaborating centre for drug utilization research and clinical pharmacological services. Available: http://apps.who.int/medicinedocs/en/d/Js4876e. Date of access: 9 December 2009.
WHO. 2003b. Drug and therapeutics committees: a practical guide. Available:
http://apps.who.int/medicinedocs/en/d/Js4882e/6.5.html. Date of access: 4 September 2012. WHO. 2003c. Introduction to drug utilization research. Available:
http://www.whocc.no/filearchive/publications/drug_utilization_research.pdf. Date of access: 6 October 2011.
WHO. 2005. Preventing chronic diseases- a vital investment. Available:
http://whqlibdoc.who.int/publications/2005/9241563001_eng.pdf. Date of access : 29 July 2010. WHO. 2006a. International statistical classification of diseases and related health problems. 10th revision. Available: http://www3.who.int/icd/currentversion/fr-icd.htm. Date of access: 8 June 2009.
WHO. 2006b. The world health report 2006: Working together for health. Available: http://www.who.int/whr/2006/en/. Date of access: 5 December 2011.
WHO.2007a. ATC/DDD Index 2007. Available: http://www.whocc.no/atcddd/indexdatabase/. Date of access: 17 February 2009.
